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Introduction
Globally, diabetic foot ulcers are one of the major public 
health problems leading to socioeconomic burden to the 
suffering individuals.[1,2] Around 15% of all diabetic patients 
develop a foot ulcer that is highly vulnerable to infections, at 
some time in their life.[3] Foot ulcer infections usually spread 
rapidly on account of polymicrobial growth, predominantly 
consisting of aerobic, Gram-positive and Gram-negative 
organisms.[4,5] In recent years, the number of the incidents 
and complications-related to diabetic foot infections (DFIs) 
has drastically increased due to increased incidence of 
multidrug-resistant organisms.[6]	Currently,	there	is	a	deficit	of	
data on these causatives in diabetic foot, especially in this part 
of the world. Manipal is located in a region with high literacy, 
low infant mortality and better access to health care. In this 
context, data from this region is also likely to be different from 
data gathered in other parts of rural India.
Adequate management of these infections needs appropriate 
antibiotic selection on the basis of culture and susceptibility test 
reports.[7] Usually initial management often comprises empirical 
antimicrobial treatment based on local epidemiological data of 
antimicrobial susceptibility. Knowledge of microbes that cause 
infections is helpful in determining proper antibiotic therapy.[3] 
Hence, this pilot study was undertaken in order to investigate 
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the antimicrobial susceptibility pattern of microbes isolated 
from diabetic foot ulcers.
Subjects and Methods
A cross-sectional study was conducted in the Department 
of General Surgery, KMC Hospital, Manipal for a period of 
6 months (July 1, 2011–December 31, 2011). During this period, 
2892 patients’ admission details in the general surgery wards were 
tracked	from	the	hospital	data	management	system,	and	identified	
newly diagnosed 108 diabetic foot ulcer patients. Informed 
consents were obtained from all the eligible subjects. These 
patients’ pus samples (for bacterial culture) were obtained at the 
time of admission before starting antibiotic therapy. Wound swabs 
or pus were collected (deep tissue specimens produce better results 
than	superficial	swabs,	especially	when	osteomyelitis	is	suspected.	
However, deep tissue specimens are not always practical or 
available). These specimens were examined as Gram-stained 
smear and cultured aerobically on blood agar and MacConkey 
agar plates. Antimicrobial susceptibility test was performed by 
disc diffusion technique according to Clinical and Laboratory 
Standards Institute guidelines. Anaerobic culture was not done 
due to lack of resources for handling anaerobic samples. Hence, 
results	were	analyzed	for	aerobic	flora	only.	Before	beginning	
the study, ethical clearance was obtained from the Institutional 
Ethical Committee.
Results and Discussion
Baseline characteristics of the 108 diabetic foot ulcer patients 
taken for the study showed 72.2% (78/108) were males and 
27.8% (30/108) were females [Table 1]. Increased male 
prevalence has been reported in other studies.[3,4] This may 
be due to higher levels of outdoor activity among males than 
females. The mean (SD) age of the subjects was 58.3 (7.4) 
years. The mean (SD) duration of diabetes and hospital 
stay was 5.6 (4.1) years and 11.6 (7.1) days, respectively. 
Ulcers were located on plantar digit 33.3% (36/108), plantar 
metatarsal 22.2% (24/108), dorsal digit 16.7% (18/108), 
heel 16.7% (18/108), and lateral metatarsal 11.1% (12/108). 
22.2% (24/108) patients had a previous history of amputation. 
Of the 108 specimens from the diabetic foot lesions, 
culture showed polymicrobial growth in 44.4% (48/108), 
monomicrobial growth in 44.4% (48/108), and no growth 
in 11.1% (12/108). Polymicrobial nature of DFIs has been 
reported from several studies conducted both in this region and 
abroad.[4] Lipsky, et al. have reported the majority of DFIs are 
polymicrobial nature with aerobic Gram-positive cocci, and 
especially staphylococci, the most common causative agents.[5] 
Different result was found by Tiwari et al. study, in which 
monomicrobial infections cases (43.5%, 27/62) were more 
than polymicrobial infections (35.5%, 22/62).[8]
Organisms isolated from the DFIs are presented in Table 2. 
Microbiological evaluation of diabetic foot ulcer infections 
showed that the prevalence of Gram-negative organisms 
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Table 2: Bacteria isolated from diabetic foot infections of 
96 patients
Bacteria Number Percentage
Gram‑positive aerobes 66 44
S. aureus (MSSA) 42 28
Enterococcus species 12 8
Beta haemolyic streptococci 6 4
S. aureus (MRSA) 6 4
Gram‑negative aerobes 84 56
P. aeruginosa 36 24
E. coli 12 8
K. pneumonia 12 8
K. oxytoca (ESBL) 6 4
P. mirabilis (ESBL) 6 4
P. vulgaris 6 4
Acinetobacter 6 4
ESBL: Extended spectrum beta lactamase, MRSA: Methicillin resistant S. aureus, 
MSSA: Methicillin-sensitive S. aureus, S. aureus: Staphylococcus aureus, 
P. aeruginosa: Pseudomonas aeruginosa, E. coli: Escherichia coli, 
K. pneumonia: Klebsiella pneumonia, P. vulgaris: Proteus vulgaris, P. mirabilis: Proteus 
mirabilis, K. oxytoca: Klebsiella oxytoca
(56%, 84/150) were found to be more than Gram-positive 
organisms (44%, 66/150) which is in accordance with earlier 
studies.[1] However, Staphylococcus aureus was the most 
frequent pathogen (28%, 42/150), followed by Pseudomonas 
aeruginosa (24%, 36/150). Almost similar results were obtained 
by two Indian studies.[3,4] Zubair et al. study conducted in North 
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India also found Gram-negative aerobes were most frequent 
organisms (63.8%, 65/102) and Gram-positive aerobes (36.1%, 
37/102).[9] Al Benwan, et al. also reported Gram-negatives 
were more prevalent, but predominant organisms isolated were 
members of the Enterobacteriaceae.[10] This study revealed 
that multidrug-resistant (MDR) organisms are very common 
in hospitalized patients with diabetic foot ulcers. This is in 
line with the report of Gadepalli, et al. study.[3] Zubair et al. 
noticed 45% (46/102) of diabetic foot ulcers were present 
MDR organisms.[9]
The antimicrobial susceptibility pattern of the Gram-positive 
and Gram-negative organisms are shown in Table 3. S. aureus 
isolates were 100% (48/48) sensitive to cotrimoxazole and 
totally	resistant	to	ciprofloxacin.	However,	some	previous	studies	
reported	sensitivity	 to	ciprofloxacin.[4] The rate of Methicillin 
Resistant S. aureus (MRSA) in this study was found to be much 
lower than the studies conducted by Gadepalli, et al. and Bansal, 
et al.[3,4] MRSA was resistant to all the antibiotics except linezolid, 
doxycycline, and cotrimoxazole. Other Gram-positive cocci 
like Enterococci and Beta hemolytic streptococci isolates were 
100% (12/12, 6/6, respectively) susceptible to chloramphenicol, 
gentamicin, and doxycycline. All Gram-positive aerobes except 
Enterococci were 100% (54/54) sensitive to cotrimoxazole. 
Except MRSA, all other Gram-positive aerobes were susceptible 
to gentamicin. All Gram-positive aerobes were sensitive to 
doxycycline. Al Benwan et al., study showed vancomycin was 
the most effective antibiotics for Gram-positive bacteria.[10]
Most of studies have reported varying resistance patterns of 
P. aeruginosa toward commonly used antibiotics, but our studies 
showed a different pattern of susceptibility.[4] Extended spectrum 
beta lactamase (ESBL) producing Escherichia coli was resistant 
to most of the antibiotics except cefoperazone/sulbactam, 
meropenem, piperacillin/tazobactam, and ticarcillin/clavulanic 
acid. Similarly, Gadepalli, et al. study also observed ESBL 
producing E. coli.[3] All Gram-negative isolates (but not 
Acinetobacter) including ESBL-producing strains of Proteus 
mirabilis and Klebsiella oxytoca were highly sensitive to 
amikacin, cefoperazone/sulbactam and meropenem. Similarly, 
Table 3: Antimicrobial susceptibility (%) pattern of microbes in diabetic foot infections (n=96)





































































































































Amikacin ‑ ‑ ‑ ‑ 66.7 0 100 100 100 100 0
Ampicillin 28.5 0 100 0 ‑ ‑ 0 0 0 0 0
Augmentin 71.4 100 ‑ 0 ‑ 0 0 0 0 0
Aztreonam ‑ ‑ ‑ ‑ 100 0 ‑ 100 0 0 0
Cefazolin 66.7 ‑ ‑ 0 ‑ 0 0 0 0 0 0
Cefuroxime 71.4 ‑ ‑ 0 ‑ 0 0 0 0 0 0
Cefotaxime ‑ ‑ ‑ ‑ ‑ 0 100 100 0 0 0
Ceftazidime ‑ ‑ ‑ 0 100 ‑ ‑ ‑ ‑ ‑ ‑
Cefepime ‑ ‑ ‑ ‑ 100 0 ‑ 100 0 0 0
Chloramphenicol ‑ 100 100 ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑
Ciprofloxacin 0 0 100 0 83.3 0 100 100 0 0 0
Clindamycin 71.4 0 ‑ 0 ‑ ‑ ‑ ‑ ‑ ‑ ‑
Cefoperazone/sulbactam ‑ ‑ ‑ ‑ 100 100 ‑ 100 100 100 0
Doxycycline 85.7 100 100 100 ‑ ‑ ‑ ‑ ‑ ‑‑ ‑
Erythromycin 71.4 0 100 0 ‑ ‑ ‑ ‑ ‑ ‑ ‑
Gentamicin 83.3 100 100 0 66.7 0 100 0 0 0 0
Linezolid ‑ ‑ ‑ 100 ‑ ‑ ‑ ‑ ‑ ‑ ‑
Meropenem ‑ ‑ ‑ ‑ 100 100 ‑ 100 100 100 0
Netilmycin ‑ ‑ ‑ ‑ 75 0 ‑ 100 0 100 0
Norfloxacin ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑
Oxacillin 100 ‑ ‑ 0 ‑ ‑ ‑ ‑ ‑ ‑ ‑
Penicillin ‑ ‑ 100 ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑
Pipercillin ‑ ‑ ‑ ‑ 100 ‑ ‑ ‑ ‑ ‑ ‑
Pipercillin/tazobactam ‑ ‑‑ ‑‑ ‑ 100 100 100 100 ‑ 0 0
Ticarcillin/clavulanic acid ‑ ‑ ‑ ‑ 100 100 ‑ 100 0 0 0
TMP/SMX 100 0 100 100 0 0 0 0 100 0
Tobramycin ‑ ‑ ‑ ‑ 66.7 ‑ ‑ ‑ ‑ ‑ ‑
S. aureus: Staphylococcus aureus, P. aeruginosa: Pseudomonas aeruginosa, E. coli: Escherichia coli, K. pneumonia: Klebsiella pneumonia, P. vulgaris: Proteus vulgaris, 
P. mirabilis: Proteus mirabilis, K. oxytoca: Klebsiella oxytoca, ESBL: Extended spectrum beta lactamase, MRSA: Methicillin resistant S. aureus, MSSA: Methicillin-sensitive S. aureus
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Al Benwan et al. have reported imipenem, piperacillin-tazobactam 
and amikacin were the most effective antibiotics for Gram-negative 
bacteria.[10] Acinetobacter was totally resistant to all the common 
antibiotics tested. This was in accordance with multidrug-resistant 
Acinetobacter isolates from Bansal, et al. study.[4] The main 
limitations of our study are a small sample size and the specimen 
used for the culture that is wound swab and pus.
Conclusion
This study showed most common organisms present in the 
diabetic foot ulcer were Gram-negative aerobes. However, 
S. aureus was the most predominant organism isolated from the 
lesions. There were equal proportions of monomicrobial and 
polymicrobial cultures noticed in the DFIs. Presence of MDR 
organisms was alarmingly high in the diabetic foot ulcers. These 
observations are important, especially for patient management 
and the development of antibiotic treatment guidelines. 
Moreover, increasing prevalence of MDR organisms raises 
serious concerns because MDR infections limit the choice of 
antibiotic therapy and may lead to poor prognosis. Findings of 
this study propose that large prospective studies are essential 
to assess the suitable empirical antibiotic regimen in diabetic 
foot ulcer infections. This study also directed us toward 
proper treatment strategies for the management of diabetic 
foot ulcers with appropriate antibiotics such as doxycycline 
and gentamicin for Gram-positive cocci and amikacin, 
cefoperazone/sulbactam and meropenem for Gram-negative 
bacilli. Clinical guidelines must be implemented to cut the 
incidence of MDR bacteria in this population and for better 
patient’s outcomes. Simultaneously, we have to seek effective 
agents for microbes such as MDR Acinetobacter.
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